Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Jun;118(3):790–796. doi: 10.1111/j.1476-5381.1996.tb15469.x

Effects of selective phosphodiesterase 3 inhibition in the perfused liver of the rat after endotoxin treatment.

H Weidenbach 1, K Beckh 1, M Burger 1, T Schricker 1, M Georgieff 1, G Adler 1
PMCID: PMC1909729  PMID: 8762109

Abstract

1. This study was designed to investigate the role of rat phosphodiesterase 3 (RPDE3) in regulation of liver metabolism in sepsis. We studied the effects of the phosphodiesterase 3 inhibitor (PDI), enoximone, alone and in combination with regulating factors of hepatic carbohydrate metabolism and bile secretion in the perfused liver of rats treated 4 h earlier with endotoxin. In addition, cyclic AMP and cyclic GMP levels were determined in the effluate and bile by radio immunoassay methods. 2. After endotoxin treatment, infusion of enoximone at three concentrations (1 microM, 10 microM) resulted in an increased glucose output from -1.4 +/- 0.9 to 7.8 +/- 2.5 mumol l-1 20 min-1. Bile acid-independent bile flow increased also, in a dose-dependent manner. 3. In untreated livers, cyclic AMP release increased in the effluate from 1000 +/- 73 fmol g-1 min-1 to 1710 +/- 143 fmol g-1 min-1 when enoximone (10 microM) was administered. In bile from untreated livers, the level of cyclic AMP was also significantly increased by enoximone. After endotoxin treatment, the enoximone (10 microM) effect on cyclic AMP levels in effluate and bile was greatly reduced. Levels of cyclic GMP in the effluate and bile appeared unchanged in the presence of enoximone. 4. During co-infusion of glucagon (1 nM) and enoximone (10 microM), cyclic nucleotide levels in the effluate and bile of livers after endotoxin treatment were determined. In the effluate, cyclic AMP release increased from 827 +/- 144 fmol g-1 min-1 to 17802 +/- 2821 fmol g-1 min-1 when glucagon was administered. The presence of enoximone enhanced cyclic AMP further to 41696 +/- 920 fmol g-1 min-1. The same changes in cyclic AMP release were found in bile. Levels of cyclic GMP in the effluate and bile were not significantly affected by the administration of glucagon and the PDI. 5. Glucose release was determined during glucagon, sympathetic nerves stimulation and phenylephrine administration in the presence and absence of enoximone. The addition of enoximone to glucagon increased glucose release by 8.2 +/- 2.8 mumol g-1 20 min-1, without alteration of lactate balance. The PDI enhanced the glycogenolytic effects of nerve stimulation and of phenylephrine, accompanied by a reduction in lactate production. 6. Enoximone significantly enhanced the bile acid independent bile flow after glucagon, nerves stimulation and after administration of phenylephrine. Bile acid secretion was unaffected by the PDI. The vasoconstrictor effect of nerve stimulation was reduced by the PDI. 7. We conclude that endotoxin treatment reduces the ability of the PDI, enoximone, to increase cyclic AMP release in the perfused liver. The significant increase in cyclic AMP release after stimulation with glucagon and enoximone favours the view that RPDE3 is involved in the degradation of cyclic AMP in the liver after exposure to endotoxin. Additionally, the inhibition of the RPDE3 results in glucose release, vasodilatation and choleresis in endotoxin pretreated livers.

Full text

PDF
790

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bagdade J. D., Root R. K., Bulger R. J. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes. 1974 Jan;23(1):9–15. doi: 10.2337/diab.23.1.9. [DOI] [PubMed] [Google Scholar]
  2. Beckh K., Arnold R. Regulation of bile secretion by sympathetic nerves in perfused rat liver. Am J Physiol. 1991 Nov;261(5 Pt 1):G775–G780. doi: 10.1152/ajpgi.1991.261.5.G775. [DOI] [PubMed] [Google Scholar]
  3. Beckh K., Kneip S., Arnold R. Direct regulation of bile secretion by prostaglandins in perfused rat liver. Hepatology. 1994 May;19(5):1208–1213. [PubMed] [Google Scholar]
  4. Brønstad G. O., Christoffersen T. Inhibitory effect of prostaglandins on the stimulation by glucagon and adrenaline of formation of cyclic AMP in rat hepatocytes. Eur J Biochem. 1981 Jul;117(2):369–374. doi: 10.1111/j.1432-1033.1981.tb06347.x. [DOI] [PubMed] [Google Scholar]
  5. Casteleijn E., Kuiper J., Van Rooij H. C., Kamps J. A., Koster J. F., Van Berkel T. J. Endotoxin stimulates glycogenolysis in the liver by means of intercellular communication. J Biol Chem. 1988 May 25;263(15):6953–6955. [PubMed] [Google Scholar]
  6. Ceppi E. D., Knowles R. G., Carpenter K. M., Titheradge M. A. Effect of treatment in vivo of rats with bacterial endotoxin on fructose 2,6-bisphosphate metabolism and L-pyruvate kinase activity and flux in isolated liver cells. Biochem J. 1992 Jun 15;284(Pt 3):761–766. doi: 10.1042/bj2840761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Colucci W. S., Wright R. F., Braunwald E. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1. N Engl J Med. 1986 Jan 30;314(5):290–299. doi: 10.1056/NEJM198601303140506. [DOI] [PubMed] [Google Scholar]
  8. Eckly A. E., Lugnier C. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway. Br J Pharmacol. 1994 Oct;113(2):445–450. doi: 10.1111/j.1476-5381.1994.tb17009.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Filkins J. P., Cornell R. P. Depression of hepatic gluconeogenesis and the hypoglycemia of endotoxin shock. Am J Physiol. 1974 Oct;227(4):778–781. doi: 10.1152/ajplegacy.1974.227.4.778. [DOI] [PubMed] [Google Scholar]
  10. Grous M., Barnette M. Prevention by phosphodiesterase inhibitors of antigen-induced contraction of guinea-pig colonic smooth muscle. Br J Pharmacol. 1994 Jan;111(1):259–263. doi: 10.1111/j.1476-5381.1994.tb14053.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hayakawa T., Bruck R., Ng O. C., Boyer J. L. DBcAMP stimulates vesicle transport and HRP excretion in isolated perfused rat liver. Am J Physiol. 1990 Nov;259(5 Pt 1):G727–G735. doi: 10.1152/ajpgi.1990.259.5.G727. [DOI] [PubMed] [Google Scholar]
  12. Hwang T. L., Lau Y. T., Huang S. F., Chen M. F., Liu M. S. Changes of alpha 1-adrenergic receptors in human liver during intraabdominal sepsis. Hepatology. 1994 Sep;20(3):638–642. [PubMed] [Google Scholar]
  13. Kauffman R. F., Schenck K. W., Utterback B. G., Crowe V. G., Cohen M. L. In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides. J Pharmacol Exp Ther. 1987 Sep;242(3):864–872. [PubMed] [Google Scholar]
  14. Lenzen R., Hruby V. J., Tavoloni N. mechanism of glucagon choleresis in guinea pigs. Am J Physiol. 1990 Nov;259(5 Pt 1):G736–G744. doi: 10.1152/ajpgi.1990.259.5.G736. [DOI] [PubMed] [Google Scholar]
  15. Liu M. S., Ghosh S. Changes in beta-adrenergic receptors in dog livers during endotoxic shock. Am J Physiol. 1983 May;244(5):R718–R723. doi: 10.1152/ajpregu.1983.244.5.R718. [DOI] [PubMed] [Google Scholar]
  16. Lugnier C., Schoeffter P., Le Bec A., Strouthou E., Stoclet J. C. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta. Biochem Pharmacol. 1986 May 15;35(10):1743–1751. doi: 10.1016/0006-2952(86)90333-3. [DOI] [PubMed] [Google Scholar]
  17. Luster M. I., Germolec D. R., Yoshida T., Kayama F., Thompson M. Endotoxin-induced cytokine gene expression and excretion in the liver. Hepatology. 1994 Feb;19(2):480–488. [PubMed] [Google Scholar]
  18. Okada F., Nagao S., Harada Y., Xavier R. M., Nakamura M., Ishida T., Tanigawa Y. The role of cyclic AMP in the lipopolysaccharide-induced suppression of thymidine kinase activity in macrophage. Biochim Biophys Acta. 1995 Mar 16;1265(2-3):201–208. doi: 10.1016/0167-4889(94)00228-7. [DOI] [PubMed] [Google Scholar]
  19. Parker M. M., Parrillo J. E. Septic shock. Hemodynamics and pathogenesis. JAMA. 1983 Dec 23;250(24):3324–3327. [PubMed] [Google Scholar]
  20. Pyne N. J., Cooper M. E., Houslay M. D. The insulin- and glucagon-stimulated 'dense-vesicle' high-affinity cyclic AMP phosphodiesterase from rat liver. Purification, characterization and inhibitor sensitivity. Biochem J. 1987 Feb 15;242(1):33–42. doi: 10.1042/bj2420033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Raetz C. R., Ulevitch R. J., Wright S. D., Sibley C. H., Ding A., Nathan C. F. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J. 1991 Sep;5(12):2652–2660. doi: 10.1096/fasebj.5.12.1916089. [DOI] [PubMed] [Google Scholar]
  22. Shangraw R. E., Jahoor F., Miyoshi H., Neff W. A., Stuart C. A., Herndon D. N., Wolfe R. R. Differentiation between septic and postburn insulin resistance. Metabolism. 1989 Oct;38(10):983–989. doi: 10.1016/0026-0495(89)90010-3. [DOI] [PubMed] [Google Scholar]
  23. Turley S. D., Dietschy J. M. Re-evaluation of the 3 alpha-hydroxysteroid dehydrogenase assay for total bile acids in bile. J Lipid Res. 1978 Sep;19(7):924–928. [PubMed] [Google Scholar]
  24. Utili R., Abernathy C. O., Zimmerman H. J. Cholestatic effects of Escherichia coli endotoxin endotoxin on the isolated perfused rat liver. Gastroenterology. 1976 Feb;70(2):248–253. [PubMed] [Google Scholar]
  25. Verghese M. W., McConnell R. T., Lenhard J. M., Hamacher L., Jin S. L. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells. Mol Pharmacol. 1995 Jun;47(6):1164–1171. [PubMed] [Google Scholar]
  26. Vincent J. L., Domb M., Van der Linden P., Motte S., de Boelpaepe C., Contempré B., Cantraine F. Amrinone administration in endotoxin shock. Circ Shock. 1988 Jun;25(2):75–83. [PubMed] [Google Scholar]
  27. Weidenbach H., Beckh K., Günthör M., Lerch M. M., Adler G. The role of nitric oxide in hemodynamic and metabolic alterations induced by prostaglandin F2 alpha in the perfused rat liver. Biochim Biophys Acta. 1995 Oct 19;1245(2):181–186. doi: 10.1016/0304-4165(95)00090-x. [DOI] [PubMed] [Google Scholar]
  28. Weidenbach H., Beckh K., Schricker T., Georgieff M., Adler G. Enhancement of hepatic glucose release and bile flow by the phosphodiesterase-III-inhibitor enoximone in the perfused rat liver. Life Sci. 1995;56(20):1721–1726. doi: 10.1016/0024-3205(95)98579-5. [DOI] [PubMed] [Google Scholar]
  29. Wettstein M., Gerok W., Häussinger D. Endotoxin-induced nitric oxide synthesis in the perfused rat liver: effects of L-arginine and ammonium chloride. Hepatology. 1994 Mar;19(3):641–647. doi: 10.1002/hep.1840190315. [DOI] [PubMed] [Google Scholar]
  30. Youssef J., Abdel-aleem S., Badr M. Enoximone inhibits hepatic mitochondrial long-chain acyl-CoA synthetase. Toxicol Lett. 1994 Oct;74(1):15–21. doi: 10.1016/0378-4274(94)90070-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES